A recombinant bi-specific antibody targeting CD30 on Hodgkin's lymphoma cells and the Fc γ receptor (CD64) on monocytes triggers CD64 mediated effector functions [15]. This evidence concerns the gene FCGR1A and Hodgkins lymphoma.